TCI Wealth Advisors’s Serina Therapeutics SER Stock Holding History

TCI Wealth Advisors’s Portfolio SER Stock Details SER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4	Closed	–	–	1571
2018 Q4	$0	Buy	+4	New	+$509	﹤0.01%	1688

Other funds holding SER

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

PCM

Price Capital Management Lafayette, Louisiana $7.05M AUM 47.39% 1-Year Est. Return

TCI Wealth Advisors's SER Position: Q1 2019 in Review

TCI Wealth Advisors sold out of Serina Therapeutics (SER) in Q1 2019, closing a stake of 4 shares.

TCI Wealth Advisors first reported a position in SER in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 59 funds tracked by Wall St. Rank hold SER as of Q1 2019.

TCI Wealth Advisors reported no remaining Serina Therapeutics position as of Q1 2019 after selling out during the quarter.
TCI Wealth Advisors sold 4 Serina Therapeutics shares in Q1 2019.
TCI Wealth Advisors first reported a position in Serina Therapeutics in Q4 2018 and held it in 1 quarter.
TCI Wealth Advisors's Serina Therapeutics position peaked at $0 in Q4 2018.
59 funds tracked by Wall St. Rank held Serina Therapeutics as of Q1 2019.

Based on TCI Wealth Advisors's 13F filing for Q1 2019, filed 11 Apr 2019.